Bandingkan Harga & Kinerja Bank Artha Graha Internasional Tbk. (INPC) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Artha Graha Internasional Tbk. dan Organon Pharma Indonesia Tbk.: Bank Artha Graha Internasional Tbk. diperdagangkan di Rp160 (kapitalisasi pasar 3,26 T, volume 24 jam 5,45 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bank Artha Graha Internasional Tbk. jauh lebih besar — sekitar 31,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INPC | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,26 T | 104,4 M |
Volume | 5,45 jt | — |
Lot | 54,46 rb | — |
Perputaran | 868,19 jt | — |
Harga Rata-rata | 159,41 | — |
Nilai Transaksi | 868,19 jt | — |
Harga Ekuilibrium Indikatif | 160 | — |
Volume Ekuilibrium Indikatif | 402 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Artha Graha Internasional Tbk.
PT Bank Artha Graha Internasional Tbk (“the Bank”) initially was established under the name of PT Inter-Pacific Financial Corporation based on notarial deed No. 12 dated September 7, 1973 of Bagijo, SH, substitute notary of Eliza Pondaag, SH, Notary in Jakarta. PT Bank Inter Pacific, Tbk is a joint venture bank that for the previous period of 20 years operated as Non Bank Financial Institution (NBFI) and went public in August 1990.
Selengkapnya di halaman INPC →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
